NO933239L - - Google Patents

Info

Publication number
NO933239L
NO933239L NO933239A NO933239A NO933239L NO 933239 L NO933239 L NO 933239L NO 933239 A NO933239 A NO 933239A NO 933239 A NO933239 A NO 933239A NO 933239 L NO933239 L NO 933239L
Authority
NO
Norway
Prior art keywords
hours
active ingredient
mucoadhering
approx
product
Prior art date
Application number
NO933239A
Other languages
English (en)
Other versions
NO933239D0 (no
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/104,785 external-priority patent/US5458884A/en
Application filed filed Critical
Publication of NO933239D0 publication Critical patent/NO933239D0/no
Publication of NO933239L publication Critical patent/NO933239L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/122—Foams; Dry foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S261/00—Gas and liquid contact apparatus
    • Y10S261/26—Foam

Abstract

Et muko-adherende, oppløselig produkt for administrering av aktive bestanddeler omfatter et lyofilisert skum og en aktiv bestanddel med en oppløsningstid på minst ca. 8 timer og fortrinnsvis minst ca. 24 timer. Oppfinnelsens innretning muliggjør forsinket og/eller kontrollert avgivelse av en aktiv bestanddel i opptil 24 timer. En fremgangsmåte for fremstilling av produktet anvender en kontinuerlig, lukket blandelnnretning som er i stand til å arbeide under trykk.
NO933239A 1992-09-10 1993-09-10 Bioeroderbar innretning for administering av aktive ingredienser NO933239D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US94336092A 1992-09-10 1992-09-10
US08/104,785 US5458884A (en) 1992-09-10 1993-08-16 Bioerodible device for administering active ingredients

Publications (2)

Publication Number Publication Date
NO933239D0 NO933239D0 (no) 1993-09-10
NO933239L true NO933239L (no) 1994-05-04

Family

ID=26801936

Family Applications (1)

Application Number Title Priority Date Filing Date
NO933239A NO933239D0 (no) 1992-09-10 1993-09-10 Bioeroderbar innretning for administering av aktive ingredienser

Country Status (4)

Country Link
US (2) US5650192A (no)
CA (1) CA2105887C (no)
FI (1) FI933979A0 (no)
NO (1) NO933239D0 (no)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8765177B2 (en) * 1997-09-12 2014-07-01 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
US7153845B2 (en) * 1998-08-25 2006-12-26 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
US6624200B2 (en) 1998-08-25 2003-09-23 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
US6248358B1 (en) 1998-08-25 2001-06-19 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets and methods of making and using the same
US6977083B1 (en) 1998-10-02 2005-12-20 Jenapharm Gmbh & Co. Kg Bioadhesive tablet containing testosterone/testosterone ester mixtures and method for producing a predetermined testosterone time-release profile with same
US6552024B1 (en) 1999-01-21 2003-04-22 Lavipharm Laboratories Inc. Compositions and methods for mucosal delivery
US6159491A (en) * 1999-02-12 2000-12-12 Biovector Technologies, Inc. Prolonged release bioadhesive vaginal gel dosage form
US20040115252A1 (en) * 1999-06-25 2004-06-17 Thomas Leon Methods of treating illnesses in non-human mammals
BR0007360A (pt) * 1999-12-23 2001-08-14 Johnson & Johnson Composição de liberação controlada
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
US6756051B1 (en) 2000-11-15 2004-06-29 Li-Lan H. Chen Bioadhesive, closed-cell foam film, sustained release, delivery devices and methods of making and using same
KR20030086579A (ko) * 2000-11-26 2003-11-10 마그넷노우츠, 리미티드 자성 기판, 그 조성물 및 제조방법
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
MXPA05004278A (es) 2002-10-25 2005-10-05 Foamix Ltd Espuma cosmetica y farmaceutica.
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US8486376B2 (en) 2002-10-25 2013-07-16 Foamix Ltd. Moisturizing foam containing lanolin
US8119150B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Non-flammable insecticide composition and uses thereof
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US8119109B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Foamable compositions, kits and methods for hyperhidrosis
JP2006512409A (ja) * 2002-10-31 2006-04-13 ユーエムディー， インコーポレイテッド 薬物送達用治療組成物で被覆上皮に対するもの及びそれを介するもの
US7575739B2 (en) 2003-04-28 2009-08-18 Foamix Ltd. Foamable iodine composition
US7077176B2 (en) * 2003-04-28 2006-07-18 Medical Instill Technologies, Inc. Container with valve assembly for filling and dispensing substances, and apparatus and method for filling
US7306812B2 (en) 2003-05-09 2007-12-11 Cephalon, Inc. Dissolvable backing layer for use with a transmucosal delivery device
US7276246B2 (en) * 2003-05-09 2007-10-02 Cephalon, Inc. Dissolvable backing layer for use with a transmucosal delivery device
US8486374B2 (en) 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
DE102004007526A1 (de) * 2004-02-17 2005-09-01 Oetjen, Georg-Wilhelm, Dr. Verfahren und Einrichtung zur Gefriertrocknung von Produkten
EP2013113B1 (en) * 2006-04-24 2018-03-21 Medical Instill Technologies, Inc. Needle penetrable and resealable lyophilization device and related method
EP1870649A1 (en) 2006-06-20 2007-12-26 Octapharma AG Lyophilisation targetting defined residual moisture by limited desorption energy levels
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
PL1986473T3 (pl) * 2007-04-03 2017-07-31 Tsinghua University Organiczne urządzenie elektroluminescencyjne
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
WO2009069006A2 (en) 2007-11-30 2009-06-04 Foamix Ltd. Foam containing benzoyl peroxide
WO2010041141A2 (en) 2008-10-07 2010-04-15 Foamix Ltd. Oil-based foamable carriers and formulations
WO2009072007A2 (en) 2007-12-07 2009-06-11 Foamix Ltd. Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
CA2712120A1 (en) 2008-01-14 2009-07-23 Foamix Ltd. Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
WO2009148442A1 (en) 2008-06-04 2009-12-10 Colgate-Palmolive Company Oral care implement with cavitation system
WO2010125470A2 (en) 2009-04-28 2010-11-04 Foamix Ltd. Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
WO2011013009A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
CA2769677A1 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
EP2459152A2 (en) * 2009-07-30 2012-06-06 The Procter & Gamble Company Oral care article
CA2776474C (en) 2009-10-02 2021-01-12 Foamix Ltd. Topical tetracycline compositions
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
US9545376B2 (en) 2013-01-23 2017-01-17 Arx, Llc Production of unit dose constructs
MX2020012139A (es) 2016-09-08 2021-01-29 Vyne Pharmaceuticals Inc Composiciones y metodos para tratar rosacea y acne.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3309779A (en) * 1966-02-02 1967-03-21 Fmc Corp Dehydration of solids-bearing liquids
CH528266A (fr) * 1969-11-26 1972-09-30 Orsymonde Procédé pour la préparation d'une composition lyophilisée à l'usage cosmétique ou hygiénique
FR2513478A1 (fr) * 1981-09-24 1983-03-25 Automatismes Tech Avancees Procede et machine pour decouper dans un fil electrique des troncons de longueurs determinees et pour traiter et equiper les deux extremites de ces troncons
US4642903A (en) * 1985-03-26 1987-02-17 R. P. Scherer Corporation Freeze-dried foam dosage form
US4948580A (en) * 1988-12-08 1990-08-14 E. R. Squibb & Sons, Inc. Muco-bioadhesive composition
US5354558A (en) * 1992-09-10 1994-10-11 Mcneil-Pcc, Inc. Bioerodible contraceptive suppository
US5458884A (en) * 1992-09-10 1995-10-17 Britton; Peter Bioerodible device for administering active ingredients

Also Published As

Publication number Publication date
US5891458A (en) 1999-04-06
CA2105887A1 (en) 1994-03-11
FI933979A0 (fi) 1993-09-10
CA2105887C (en) 2004-03-16
US5650192A (en) 1997-07-22
NO933239D0 (no) 1993-09-10

Similar Documents

Publication Publication Date Title
NO933239L (no)
PT643963E (pt) Dispositivo biodegradavel para administracao de substancias activas
FR2688422B1 (no)
DK0918507T3 (da) Aerosolformuleringer
EP0943328A3 (en) Combination therapy for prophylaxis and/or treatment of benign prostatic hyperplasia
ATE192921T1 (de) Therapeutischer wirkstoff zur behandlung von melanomen
ZA94413B (en) Pharmaceutical formulation for the treatment of nicotine dependence
DK0848607T3 (da) Farmaceutiske præparater og anordninger til administration deraf
UA35611C2 (uk) Композиція місцевого застосування для інгібування росту волос у ссавців, спосіб із її використанням та композиція місцевого застосування для доставки водорозчинного фармакологічного засобу до шкіри
HUP9902054A1 (hu) Karbonát dihidratáz alkalmazása a makula ődéma kezelésére szolgáló gyógyszerkészítmények előállítására
ID26240A (id) Formulasi obat setengah padat yang mengandung dekstoprofen trometamol
DE69430996T2 (de) Verfahren zur trockenmischungkompression von arzneimitteln
ZA943648B (en) Medicament aerosol formulation based on fusafungine a process for its preparation and pharmaceutical compositions containing it
AU9221898A (en) Pharmaceutical coating composition and method of use
DE69622857T2 (de) Osmotische vorrichtung mit verzögerten aktivieren der wirkstofffreisetzung und vollständige arzneistofffreisetzung
CA2220301A1 (en) Osmotic device with delayed activation of drug delivery and complete drug release
AR006437A1 (es) Uso de monohidrocloruro de n-(endo-9-metil-9-azabiciclo [3.3.1]non-3-il)-1- metilimidazol-3-carboxamida, para la fabricacion de un medicamento para eltratamiento o la profilaxis de diarrea y una composicion farmaceutica que lo contiene

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application